What is the Fiscal Year for Calidi Biotherapeutics?
Date: November 13, 2026
Calidi Biotherapeutics's current fiscal year starts on January 1, 2026, and ends on December 31, 2026. Their current quarter is Q4, which ends on December 31, 2026.
Current Fiscal Year Overview
Fiscal Year Start
January 1, 2026
Fiscal Year End
December 31, 2026
Current Quarter
Q4
Current Quarter End
December 31, 2026
Quarterly Breakdown
Q1
Jan 1, 2026 – Mar 31, 2026
Q2
Apr 1, 2026 – Jun 30, 2026
Q3
Jul 1, 2026 – Sep 30, 2026
Q4
Oct 1, 2026 – Dec 31, 2026
Company Information
Headquarters
San Diego, California
Industry
Biotechnology Research
Stock Symbol
CLDI
Website
http://www.calidibio.comDescription
Calidi Biotherapeutics is developing a new modality in cancer treatment through its proprietary RedTail platform, designed for systemic delivery of modified oncolytic viruses with genetic payloads activated at the tumor site. Focused on patients with limited treatment options, the company is advancing therapies aimed at improving targeting, activity, and durability in solid tumors. Calidi continues to generate data and present at leading scientific meetings as it progresses toward early clinical data.
Use Salesmotion for Account Data and Insights
Sales professionals can use Salesmotion to access comprehensive account intelligence and automate their research. Instantly get insights on companies like Calidi Biotherapeutics and uncover key business information that drives smarter conversations.
Book a demo today to strengthen your sales strategy with powerful data and actionable insights.